Opus Genetics, Inc. (IRD) stock
IRDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.92−0.13 (-3.21%)
Close on Nov 18, 2026Market cap $326.13MP/E –Yield –
Opus Genetics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2020 it was -$6.80M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | -$6.80M | – |
| FY2019 | Dec 31, 2019 | -$3.62M | – |
See a number that looks wrong?